LGVN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 19.12%

Insider Buying (Last 12 Months): $349,999.60

Insider Selling (Last 12 Months): $2,587.50

Longeveron Insider Trading History Chart

Longeveron Share Price & Price History

^$1.68

▲ +0.035 (2.13%)

As of 03/14/2025 03:40 PM ET

Days: 30 | 90 | 365

Longeveron Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/2/2024	Khoso Baluch	Director	Sell	1,250	$2.07	$2,587.50	23,750
4/11/2024	Mohamed Wa'el Ahmed Hashad	CEO	Buy	10,638	$2.35	$24,999.30	19,616
4/11/2024	Rock Soffer	Director	Buy	31,915	$2.35	$75,000.25	208,534
4/10/2024	Joshua Hare	Insider	Buy	106,383	$2.35	$250,000.05	590,727
1/10/2024	Cathy Ross	Director	Buy	500	$13.10	$6,550.00	1,000
12/28/2023	Jeffrey Pfeffer	Director	Buy	1,000	$13.50	$13,500.00	1,500
6/29/2023	James Clavijo	CFO	Sell	500	$35.10	$17,550.00	4,730
6/27/2023	James Clavijo	CFO	Sell	853	$34.80	$29,684.40	6,230
1/27/2023	Joshua Hare	Insider	Sell	2,000	$42.80	$85,600.00	779,326
12/2/2022	Joshua Hare	Insider	Sell	2,000	$37.40	$74,800.00	781,326
10/12/2022	Joshua Hare	Insider	Sell	10,000	$36.10	$361,000.00	781,326
6/3/2022	James Clavijo	CFO	Sell	3,695	$82.60	$305,207.00	7,961
5/23/2022	Rock Soffer	Director	Sell	800	$77.80	$62,240.00	67,635
5/20/2022	Rock Soffer	Director	Sell	750	$80.60	$60,450.00	68,435
4/18/2022	Joshua Hare	Insider	Sell	1,992	$100.00	$199,200.00	791,334

See Full Table

SEC Filings (Institutional Ownership Changes) for Longeveron (NASDAQ:LGVN)

10.01% of Longeveron stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Longeveron Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/14/2025	Jane Street Group LLC	20,493	$35K	0.0%	N/A	0.138%
2/14/2025	Northern Trust Corp	18,190	$31K	0.0%	N/A	0.123%
2/11/2025	Virtu Financial LLC	30,402	$53K	0.0%	N/A	0.205%
11/16/2024	Geode Capital Management LLC	128,947	$0.25M	0.0%	+316.0%	0.898%
11/15/2024	State Street Corp	15,180	$29K	0.0%	N/A	0.106%
8/9/2024	Renaissance Technologies LLC	146,700	$0.24M	0.0%	N/A	2.311%
2/13/2024	Armistice Capital LLC	1,836,000	$2.50M	0.0%	N/A	7.312%
7/21/2023	Creative Planning	109,322	$0.37M	0.0%	N/A	0.519%
5/13/2022	Sassicaia Capital Advisers LLC	102,004	$1.41M	7.0%	N/A	0.488%
5/12/2022	Anson Funds Management LP	20,000	$0.28M	0.0%	N/A	0.096%
2/9/2022	Alps Advisors Inc.	22,124	$0.27M	0.0%	N/A	0.112%
11/16/2021	TownSquare Capital LLC	14,450	$51K	0.0%	N/A	0.076%
11/3/2021	TAP Consulting LLC	10,000	$35K	0.0%	N/A	0.052%
10/13/2021	Private Capital Group LLC	12,000	$42K	0.0%	+140.0%	0.063%
8/16/2021	Matrix Asset Advisors Inc. NY	35,000	$0.29M	0.0%	+16.7%	0.184%
8/13/2021	Renaissance Technologies LLC	38,200	$0.31M	0.0%	N/A	0.201%
8/13/2021	Geode Capital Management LLC	14,788	$0.12M	0.0%	N/A	0.078%
8/13/2021	Vanguard Group Inc.	131,260	$1.07M	0.0%	+811.5%	0.691%
5/13/2021	Matrix Asset Advisors Inc. NY	30,000	$0.20M	0.0%	N/A	0.158%

Data available starting January 2016

See Full Table

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. Longeveron Inc. was incorporated in 2014 and is headquartered in Miami, Florida.

Today's Range

Now: $1.68

$1.62

$1.70

50 Day Range

MA: $1.62

$1.33

$1.99

52 Week Range

Now: $1.68

$0.77

$6.40

Volume

48,434 shs

Average Volume

3,480,259 shs

Market Capitalization

$25.00 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.37

Who are the company insiders with the largest holdings of Longeveron?: Longeveron's top insider shareholders include:
Joshua Hare (Insider)
Rock Soffer (Director)
Khoso Baluch (Director)
Mohamed Wa'el Ahmed Hashad (CEO)
James Clavijo (CFO)
Jeffrey Pfeffer (Director)
Cathy Ross (Director)
Learn More about top insider investors at Longeveron.
Who are the major institutional investors of Longeveron?: Longeveron's top institutional investors include:
Virtu Financial LLC — 0.20%
Jane Street Group LLC — 0.14%
Northern Trust Corp — 0.12%
Learn More about top institutional investors of Longeveron stock.
Which institutional investors are buying Longeveron stock?: During the last quarter, LGVN stock was acquired by institutional investors including:
Virtu Financial LLC
Jane Street Group LLC
Northern Trust Corp
Within the last year, these company insiders have bought Longeveron stock:
Joshua Hare (Insider)
Rock Soffer (Director)
Khoso Baluch (Director)
Mohamed Wa'el Ahmed Hashad (CEO)
James Clavijo (CFO)
Learn More investors buying Longeveron stock.